Qianben Wang

11PUBLICATIONS
48CO-AUTHORS
Innate immunityMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Medical virologyPyrometallurgy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 16, 2026
Programmable mRNA 3'UTR engineering restores MHC-I and overcomes immune evasion in prostate cancer.

|May 11, 2025
SCORT-Cas13d Nanotherapy Precisely Targets the 'Undruggable' Transcription Factor HoxB13 in Metastatic Prostate Cancer In Vivo.

Zhifen Cui, Furong Huang, Kun Fang

|Nov 29, 2024
Integrative analysis identifies the atypical repressor E2F8 as a targetable transcriptional activator driving lethal prostate cancer.

Furong Huang, Kexin Li, Zhong Chen

|Feb 02, 2023
SMAD3 promotes expression and activity of the androgen receptor in prostate cancer.

Hee-Young Jeon, Majid Pornour, Hyunju Ryu

|Jul 25, 2022
Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infection.

Zhifen Cui, Cong Zeng, Furong Huang

|Jun 07, 2022
Dynamic nucleosome landscape elicits a noncanonical GATA2 pioneer model.

Tianbao Li, Qi Liu, Zhong Chen

Pageof 2

Frequent Collaborators

5 joint publications

Zhong Chen

3 joint publications

Victor X Jin

2 joint publications

Zhifen Cui

2 joint publications

Yue Zhao